These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14679375)

  • 1. Increased body weight and improved quality of life in AIDS patients following V-1 Immunitor administration.
    Jirathitikal V; Metadilogkul O; Bourinbaiar AS
    Eur J Clin Nutr; 2004 Jan; 58(1):110-5. PubMed ID: 14679375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an oral therapeutic HIV-1 vaccine on AIDS patients with CD4 count above 250 cells/mm3.
    Jirathitikal V; Bourinbaiar AS
    Acta Virol; 2004; 48(2):73-8. PubMed ID: 15462281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II placebo-controlled study of V-1 Immunitor as a therapeutic modality for treatment of HIV.
    Bourinbaiar AS; Jirathitikal V; Metadilogkul O; Sooksathan P; Paiboon P; Aemsri S; Prapai P; Chaodon K
    J Clin Virol; 2004 Dec; 31 Suppl 1():S55-62. PubMed ID: 15567095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged survival of end-stage AIDS patients immunized with therapeutic HIV vaccine V-1 Immunitor.
    Metadilogkul O; Jirathitikal V; Bourinbaiar AS
    Biomed Pharmacother; 2005 Sep; 59(8):469-73. PubMed ID: 16126364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.
    Miller K; Corcoran C; Armstrong C; Caramelli K; Anderson E; Cotton D; Basgoz N; Hirschhorn L; Tuomala R; Schoenfeld D; Daugherty C; Mazer N; Grinspoon S
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2717-25. PubMed ID: 9709937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained anabolic effects of long-term androgen administration in men with AIDS wasting.
    Grinspoon S; Corcoran C; Anderson E; Hubbard J; Stanley T; Basgoz N; Klibanski A
    Clin Infect Dis; 1999 Mar; 28(3):634-6. PubMed ID: 10194091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of nandrolone decanoate in wasting associated with HIV.
    Saha B; Rajadhyaksha GC; Ray SK
    J Indian Med Assoc; 2009 May; 107(5):295-9. PubMed ID: 19886384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome.
    Yeh S; Wu SY; Levine DM; Parker TS; Olson JS; Stevens MR; Schuster MW
    J Nutr Health Aging; 2000; 4(4):246-51. PubMed ID: 11115810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
    Gold J; Batterham MJ; Rekers H; Harms MK; Geurts TB; Helmyr PM; Silva de Mendonça J; Falleiros Carvalho LH; Panos G; Pinchera A; Aiuti F; Lee C; Horban A; Gatell J; Phanuphak P; Prasithsirikul W; Gazzard B; Bloch M; Danner SA;
    HIV Med; 2006 Apr; 7(3):146-55. PubMed ID: 16494628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vitamins, including vitamin A, on HIV/AIDS patients.
    Mehta S; Fawzi W
    Vitam Horm; 2007; 75():355-83. PubMed ID: 17368322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serodeconversion of HIV antibody-positive AIDS patients following treatment with V-1 Immunitor.
    Metadilogkul O; Jirathitikal V; Bourinbaiar AS
    J Biomed Biotechnol; 2009; 2009():934579. PubMed ID: 18989372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS.
    Garvie PA; Lensing S; Rai SN
    Pediatrics; 2007 Apr; 119(4):e893-9. PubMed ID: 17353298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
    Mulligan K; Zackin R; Clark RA; Alston-Smith B; Liu T; Sattler FR; Delvers TB; Currier JS; ;
    Arch Intern Med; 2005 Mar; 165(5):578-85. PubMed ID: 15767536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of bioelectrical impedance analysis to determine body composition changes in HIV-associated wasting.
    Klauke S; Fischer H; Rieger A; Frühauf L; Staszewski S; Althoff PH; Helm EB
    Int J STD AIDS; 2005 Apr; 16(4):307-13. PubMed ID: 15899085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
    Gelato M; McNurlan M; Freedland E
    Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.
    Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM;
    Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of testosterone in the AIDS wasting syndrome.
    Corcoran C; Grinspoon S
    AIDS Clin Care; 1999 Apr; 11(4):25-6, 33-4. PubMed ID: 11366208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.
    Jacobson JM; Pat Bucy R; Spritzler J; Saag MS; Eron JJ; Coombs RW; Wang R; Fox L; Johnson VA; Cu-Uvin S; Cohn SE; Mildvan D; O'Neill D; Janik J; Purdue L; O'Connor DK; Vita CD; Frank I;
    J Infect Dis; 2006 Sep; 194(5):623-32. PubMed ID: 16897661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight change, body image, and quality of life in HIV disease: a pilot study.
    Corless IB; Nicholas PK; McGibbon CA; Wilson C
    Appl Nurs Res; 2004 Nov; 17(4):292-6. PubMed ID: 15573338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No attrition in research on wasting therapies.
    Gilden D
    GMHC Treat Issues; 1997; 11(4/5):9, 12-6. PubMed ID: 11364378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.